V

VYNE Therapeutics
D

VYNE

3.03000
USD
0.13
(4.55%)
Market Closed
Volume
221
EPS
-1
Div Yield
-
P/E
1
Market Cap
44,696,842
OverviewSignalsIdeasNews
Related Instruments
    A
    ALIM
    0
    (0%)
    0.000000 USD
    A
    ALKS
    -0.150
    (-0.53%)
    28.200 USD
    A
    ANIK
    0.260
    (1.53%)
    17.260 USD
    A
    ARGX
    -30.67
    (-5.16%)
    563.90 USD
    B
    BHC
    -0.27000
    (-3.08%)
    8.48500 USD
    D
    DERM
    0.16000
    (3.16%)
    5.23000 USD
    E
    EOLS
    0.220
    (1.85%)
    12.110 USD
    M
    MNK
    -0.06490
    (-16.07%)
    0.33900 USD
    More
News

Title: VYNE Therapeutics

Sector: Healthcare
Industry: Biotechnology
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.